Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Single-cell heterogeneity in Sézary syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Aishwarya Iyer
  • Dylan Hennessey
  • Sandra O'Keefe
  • Jordan Patterson
  • Weiwei Wang
  • Gane Ka-Shu Wong
  • Robert Gniadecki
View graph of relations

Mycosis fungoides (MF) is a slowly progressive cutaneous T-cell lymphoma (CTCL) for which there is no cure. In the early plaque stage, the disease is indolent, but development of tumors heralds an increased risk of metastasis and death. Previous research into the genomic landscape of CTCL revealed a complex pattern of >50 driver mutations implicated in more than a dozen signaling pathways. However, the genomic mechanisms governing disease progression and treatment resistance remain unknown. Building on our previous discovery of the clonotypic heterogeneity of MF, we hypothesized that this lymphoma does not progress in a linear fashion as currently thought but comprises heterogeneous mutational subclones. We sequenced exomes of 49 cases of MF and identified 28 previously unreported putative driver genes. MF exhibited extensive intratumoral heterogeneity (ITH) of a median of 6 subclones showing a branched phylogenetic relationship pattern. Stage progression was correlated with an increase in ITH and redistribution of mutations from stem to clades. The pattern of clonal driver mutations was highly variable, with no consistent mutations among patients. Similar intratumoral heterogeneity was detected in leukemic CTCL (Sézary syndrome). Based on these findings, we propose a model of MF pathogenesis comprising divergent evolution of cancer subclones and discuss how ITH affects the efficacy of targeted drug therapies and immunotherapies for CTCL.

Original languageEnglish
JournalBlood advances
Volume4
Issue number11
Pages (from-to)2489-2500
Number of pages12
ISSN2473-9529
DOIs
Publication statusPublished - 9 Jun 2020

ID: 61800701